This purchase order is for differentiated neurons to evaluate infectivity of neurons with sars-COV2.
Ended Purchase Order Awarded
- Contract number
- 75N95020P00195
- Awardee
-
Brainxell, Inc. UEI CFGFE23M73T7
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $11,900
Award facts
- Contract value 100% obligated
- $11,900.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Madison, WI 53711, USA
- National interest action
- Coronavirus COVID-19
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract 75N95020P00195?
75N95020P00195 was awarded to Brainxell, Inc. by National Institute on Drug Abuse (National Institutes of Health) on May 1, 2020.
How much is contract 75N95020P00195 worth?
The government has obligated $11,900 on 75N95020P00195.
Which agency awarded contract 75N95020P00195?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95020P00195, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract 75N95020P00195 competed?
The extent of competition for 75N95020P00195 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award